LAUSANNE, Switzerland – October 13, 2025 – ADC Therapeutics SA (NYSE: ADCT) , a commercial-stage leader in the field of Antibody Drug Conju...Leia Mais
ADC Therapeutics Secures $60 Million PIPE Financing to Fuel ZYNLONTA® Expansion
Reviewed by wpdigital
on
13.10.25
Rating: 5